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Abstract
Background: Although the contribution of alveolar type II epithelial cell (AEC II) activities in various aspects of
respiratory immune regulation has become increasingly appreciated, our understanding of the contribution of AEC II
transcriptosome in immunopathologic lung injury remains poorly understood. We have previously established a mouse
model for chronic T cell-mediated pulmonary inflammation in which influenza hemagglutinin (HA) is expressed as a
transgene in AEC II, in mice expressing a transgenic T cell receptor specific for a class II-restricted epitope of HA.
Pulmonary inflammation in these mice occurs as a result of CD4+ T cell recognition of alveolar antigen. This model was
utilized to assess the profile of inflammatory mediators expressed by alveolar epithelial target cells triggered by antigenspecific recognition in CD4+ T cell-mediated lung inflammation.
Methods: We established a method that allows the flow cytometric negative selection and isolation of primary AEC II
of high viability and purity. Genome wide transcriptional profiling was performed on mRNA isolated from AEC II isolated
from healthy mice and from mice with acute and chronic CD4+ T cell-mediated pulmonary inflammation.
Results: T cell-mediated inflammation was associated with expression of a broad array of cytokine and chemokine genes
by AEC II cell, indicating a potential contribution of epithelial-derived chemoattractants to the inflammatory cell
parenchymal infiltration. Morphologically, there was an increase in the size of activated epithelial cells, and on the
molecular level, comparative transcriptome analyses of AEC II from inflamed versus normal lungs provide a detailed
characterization of the specific inflammatory genes expressed in AEC II induced in the context of CD4+ T cell-mediated
pneumonitis.
Conclusion: An important contribution of AEC II gene expression to the orchestration and regulation of interstitial
pneumonitis is suggested by the panoply of inflammatory genes expressed by this cell population, and this may provide
insight into the molecular pathogenesis of pulmonary inflammatory states. CD4+ T cell recognition of antigen presented
by AEC II cells appears to be a potent trigger for activation of the alveolar cell inflammatory transcriptosome.
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Background
The epithelium constitutes the interface between the
internal milieu and the external environment, and the respiratory epithelium is the initial point of contact for respiratory viruses, airborne allergens and environmental
pollutants [1]. The major function of the respiratory epithelium was at one time felt to be primarily that of a physical barrier, but recent studies clearly indicate that its cells
are metabolically very active with the capacity to modulate a variety of inflammatory processes through the
action of an array of receptor-mediated events. Upon activation, epithelial cells have the capacity to produce a
number of pro-inflammatory or regulatory mediators,
including arachidonic acid products, nitric oxide,
endothelin-1, transforming growth factor (TGF)-β,
tumour necrosis factor (TNF)-α, and cytokines such as
interleukin (IL)-1, IL-6 and IL-8 [2].
Alveolar type II epithelial cells (AEC II, granular pneumocyte, type II pneumocyte, giant corner cell) represent a
highly specialized subpopulation of the respiratory epithelium. AEC II consist of about 15% of the distal lung
cells and occupy 5% of the alveolar surface [3]. They perform a variety of important functions within the lung,
including regulation of surfactant metabolism, ion transport and alveolar repair in response to injury [4-7]. AEC II
synthesize and secrete lung surfactant, a protein-lipid
complex and surface-active material [8]. Ultrastructural
criteria used to identify alveolar type II epithelial cells are
the presence of lamellar bodies, apical microvilli and specific junctional proteins. AEC II also maintain the integrity
of alveolar epithelium by proliferation (and differentiation to type I cells) in response to injury, and tightly regulate alveolar fluid by a variety of mechanisms.
AEC II express a number of molecules necessary for the
transduction as well as the generation of signals involved
in cell-cell as well as in cell-matrix interactions. Cell-cell
interactions may be direct via contact of tight junction
proteins, or indirect via secreted and diffusible signals [9].
Consequently, AEC II have been described as integrative
units of the alveolus [10]. Interactions of AEC II with leukocytes have also been the subject of intense investigation
and there is evidence supporting a role of AEC II in accessory function in T lymphocyte activation [11,12]. Moreover AEC II chemokine expression is induced upon
antigen-specific CD8+ T cell recognition and plays a critical role in the perpetuation of experimental interstitial
pneumonia [13,14].
In order to study the pathophysiology of chronic T cellmediated lung injury, we established a novel model in
which a model antigen (influenza A/PR8/34 HA) is
expressed under the control of the SP-C promoter, resulting in AEC II cell-specific expression and bred these ani-
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mals with mice expressing a transgenic T cell receptor,
specific for a class II-restricted epitope of HA, leading to a
chronic interstitial pneumonitis [15]. Initial characterization of these mice focussed on self-antigen specific T cell
function and revealed the induction of peripheral T cell
tolerance at the site of inflammation. In this study we
demonstrate altered AEC II cell morphology in mice with
CD4+ T cell-mediated pulmonary inflammation suggesting a state of activation that we wanted to explore at a
molecular level. As such, we established a method to isolate highly pure primary AEC II for the purpose of performing ex vivo expression profiling in the context of acute
and chronic interstitial pneumonitis. An important role of
AEC II gene expression in the orchestration of inflammatory infiltration of the lung parenchyma is suggested by a
wide array of inflammatory genes and chemoattractants
expressed upon CD4+ T cell recognition of antigen presented by the AEC II cells, and this model may prove
extremely useful in dissecting the mechanisms involved in
the perpetuation of chronic autoimmune pulmonary
processes.

Methods
Mice and antibodies
BALB/c mice were obtained from Harlan (Borchen, Germany). TCR-HA transgenic mice expressing a TCR aβ specific for the I-Ed-restricted HA-peptide 110–120 from A/
PR8/34 HA have been described previously [16]. SPC-HA
mice expressing the influenza A/PR8/34 HA under the
transcriptional control of the human surfactant protein C
(SP-C) promoter specifically in AEC II have been
described elsewhere [15]. Mice were bred in the animal
facility at the Helmholtz Centre for Infection Research
and were kept under SPF conditions. All mice were routinely monitored for the absence of bacterial, viral, parasitic and fungal infections. Mice aged 10 to 20 weeks were
used for experiments which were all performed according
to national and institutional guidelines. The monoclonal
antibody 6.5 (anti-TCR-HA) was purified from hybridoma supernatants by protein G affinity chromatography.
The antibodies a-CD45 (30-F11), a-CD16/CD32 (2.4G2),
a-CD11b (M1/70) and a-F4/80 were obtained from BD
Biosciences and used either unconjugated or as phycoerythrin (PE) conjugates. As secondary polyclonal goat arat IgM/IgG/IgA was used as phycoerythrin (PE) conjugate. For specific staining of sorted AEC II, the lectin
Maclura pomifera agglutinin was used. Intracellular staining for IFN-γ and IL-2 was performed using the antibodies
a-IFN-γ (XMG1.2) and a-IL-2 (JES6-5H4) from BD Biosciences, according to the manufacturer's protocol.
Adoptive transfer of HA-specific CD4+ T cells
Naïve CD4+ T cells from the spleens of TCR-HA mice were
isolated by negative selection by AutoMACS using the
CD4+ T cell isolation kit from Miltenyi Biotec (Bergisch
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Gladbach, Germany), followed by i.v. injection of 1 × 106
antigen-specific CD4+ T cells into SPC-HA transgenic
mice. At various time points after transfer, animals were
sacrificed and lungs perfused with PBS prior to excision.
The lungs were sectioning for histological analysis and
quantitative morphometry or were used for isolation of
AEC II cells, or infiltrating lymphocytes, as described
below.
Isolation of lymphocytes from the lung
Perfused lungs were excised and finely minced on ice, followed by a 60–90 minutes digestion at 37°C with collagenase/dispase (0,2 mg/ml each) in IMDM/5% FCS in the
presence of 25 μg/ml DNase. To improve tissue disintegration, lungs were pipeted every 5 min using a Pasteur
pipet. EDTA was added to a final concentration of 5 mM
followed by an additional 5 min incubation at 37°C.
Cells were passed through a 70 μm cell strainer, washed,
and lymphocytes isolated by density centrifugation.
Isolation of alveolar type II epithelial cells
Primary AEC II were prepared using a modified protocol
of a previously published method [17]. Briefly, mice were
anesthetized and exsanguinated by serving the inferior
vena cava and left renal artery. The tracheae was exposed
and cannulated and lungs were perfused with 10 to 20 ml
sterile phosphate buffered saline via the pulmonary artery
until visually free of blood. 2 ml dispase (BD Biosciences,
Heidelberg, Germany) was instilled into lungs via the tracheal catheter followed by instillation of 500 μl 1% lowmelt agarose prior warmed to 45°C. Instilled lungs were
immediately covered with ice and incubated for 2 min to
gel the agarose. Lungs were removed, placed in a culture
tube containing an additional 1 ml of dispase and incubated for 45 min at room temperature. The lungs were
then transferred to a culture dish and 7 ml serum free
DMEM + 25 mM HEPES (GIBCO, Eggenstein, Germany)
containing 100U/ml DNase I (Sigma, Hannover, Germany) was added. The tissue was gently teased away from
the airways using forceps and lungs were carefully dissociated before agitating the tissue for 10 min on a shaker.
Crude cell suspensions were sequentially filtered through
nylon gauze (100 μm, 45 μm, 30 μm) followed by centrifugation (12 min, 130 × g) to pellet the cells. For fluorescence activated cell sorting of alveolar type II epithelial
cells, cells were washed with serum free DMEM + 25 mM
HEPES and subsequently labelled with anti-CD45, antiCD32/CD16, anti-CD11b and anti-F4/80 antibodies and
PE-conjugated goat anti rat-IgG as secondary antibody.
After staining the cell suspension was washed with PBS
containing 2% fetal calf serum and 2 mM EDTA and subjected to one-step cell sorting using a MoFlow cell sorter
(Cytomation, Fort Collins, CO). Granular alveolar type II
epithelial cells were identified as SSChigh population. PE
(CD45/CD32/CD16/CD11b/F4/80)-positive cells were
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excited by an argon ion laser emitted at the wavelength of
488 nm and the fluorescence was collected after a 580/
±30 nm band-pass filter. A two parameter sorting window
(side light scattering and PE fluorescent intensity) was
used to identify the PE-negative, side scatter high AEC II
population. Cells were sorted through a flow chamber
with a 100 μm nozzle tip under 25 psi sheath fluid pressure. Using this protocol a purity of 97–99% and viability
of 90% was obtained. Isolated cells were either used for
immunofluorescence staining or RNA preparation.
Histology
Lungs were perfused and fixed with neutral buffered formalin, embedded in paraffin, sectioned and stained with
hematoxylin and eosin (H&E).
Immunofluorescence
For immunofluorescence staining sorted AEC II were
mounted onto glass cover slips with a density of 2 × 105
cells using a cytospin apparatus and were fixed with methanol-acetone (1:1) mixture at -20°C for 5 min. Rabbit anti
SP-A, SP-B, pro-SPC and SP-D antibodies (Chemicon
Europe, Hampshire, UK) were all diluted 1:100 and incubated with the fixed cells overnight at 4°C. A secondary
FITC conjugated goat anti-rabbit IgG (Dianova, Hamburg,
Germany) was used with a dilution of 1:80 and stained for
30 min at 37°C. All washing steps were performed in PBS
and stained cells were embedded in glycerol-PBS before
microscopic examination.
DNA microarray hybridization and analysis
Total RNA from AEC II sorted from the lung of either
healthy SPC-HA or diseased SPC-HA/TCR-HA mice was
isolated using the RNAeasy kit (Qiagen, Hilden, Germany). Quality and integrity of total RNA isolated from 2
× 105 sorted AEC II cells was assessed by running all samples on an Agilent Technologies 2100 Bioanalyser (Agilent Technologies, Waldbronn, Germany). For RNA
amplification the first round was performed in accordance
with an Affymetrix protocol without biotinylated nucleotides, using the Promega P1300 RiboMax Kit (Promega,
Mannheim, Germany) for T7 amplification. For the second round of amplification the precipitated and purified
RNA was converted to cDNA primed with random hexamers (Pharmacia, Freiburg, Germany). Second strand synthesis and probe amplification were done as in the first
round, with two exceptions: incubation with RNase H
preceded the first strand synthesis to digest the aRNA; and
the T7T23V oligonucleotide was used for initiation of the
second strand synthesis. 12.5 μg biotinylated cRNA preparation was fragmented and placed in a hybridization
cocktail containing four biotinylated hybridization controls (BioB, BioC, BioD, and Cre) as recommended by the
manufacturer. Samples were hybridized to an identical lot
of either Affymetrix MOE430A or MOE4302.0 chips for
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16 hours. After hybridization, GeneChips were washed,
stained with streptavidin-PE and read using an Affymetrix
GeneChip fluidic station scanner. Analysis was done with
gene expression software (GeneChip, MicroDB, and Data
Mining Tool, all Affymetrix).
Real-time RT-PCR
Total RNA was prepared from sorted AEC II cells using the
RNeasy kit (Qiagen, Hilden, Germany) and cDNA synthesis was done using Superscript II Reverse Transcriptase,
Oligo dT and random hexamer primers (Invitrogen).
Quantitative Real-time RT-PCR was performed on an ABI
PRISM cycler (Applied Biosystems) using a SYBR Green
PCR kit from Stratagene and specific primers optimized to
amplify 90–250 bp fragments from the various genes analyzed. A threshold was set in the linear part of the amplification curve and the number of cycles needed to reach
this was calculated for every gene. Relative mRNA levels
were determined by using included standard curves for
each individual gene and further normalization to RPS9.
Melting curves were used to establish the purity of the
amplified band.

Results
CD4+ T cell recognition of epithelial antigen results in
interstitial inflammation accompanied by AEC II
hypertrophy
We have previously shown that HA expressed by AEC II in
SPC-HA transgenic mice results in presentation of a MHC
class II-restricted epitope to CD4+ T cells and lung pathology [15]. Immunopathology, characterized by massive
lymphocytic infiltration of interalveolar septa, was
observed both in SPC-HA mice that were adoptively transferred with HA-specific CD4+ T cells as well as in SPC-HA
mice that were crossed with TCR-HA mice to establish
autoimmune conditions (Figure 1A). Interestingly, the
histologic appearance of AEC II cells in acutely inflamed
lungs revealed that they were in close contact with lymphocytes and displayed an activated phenotype with cellular hypertrophy, characterized by significantly increased
AEC II surface area and perimeter. This was most prominent during acute inflammation (i.e. shortly after adoptive transfer) and was less evident in the chronic
inflammatory state in adult SPC-HA/TCR-HA mice (Figure 1B and [15]). Accordingly, CD4+ T cells isolated from
the lung of SPC-HA mice shortly after adoptive transfer
produced elevated levels of the pro-inflammatory
cytokines IL-2 and IFN-γ compared with T cells isolated
from the lungs of SPC-HA/TCR-HA mice at 16–20 weeks
of age (Figure 2).
Isolation of type II alveolar epithelial cells
To assess the contribution of AEC II to the orchestration
and progression of T cell-mediated interstitial pneumonitis in more detail, we established a protocol for isolation
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of AEC II from the murine lung entirely by negative selection. Enzymatic digestion and antibody staining, followed by sorting of SSChigh and CD45/CD32/CD16/
CD11/F4/80negative cells, resulted in highly pure and viable
AEC II cells, as indicated by surfactant protein (SP)-A, -B,
-C and -D expression (Figure 3A,B). Identity of sorted cells
as type II pneumocytes was further confirmed by staining
with the lectin Maclura pomifera agglutinin, that specifically binds to a 185 kDa glycoprotein on AEC II but not
on alveolar type I epithelial cells (AEC I) [18]. As depicted
in Figure 3C, essentially all cells stained positive with the
lectin, demonstrating high purity of AEC II cells obtained
by negative selection cell sorting.
Global changes in AEC II gene expression following CD4+
T cell recognition of alveolar antigen
To characterize alterations in the transcriptional program
of alveolar epithelial cells in the context of T cell-mediated
interstitial pneumonitis, we performed gene expression
arrays on primary AEC II cells isolated from the lung of
either healthy SPC-HA mice or 16–20 week old SPC-HA/
TCR-HA mice with autoimmune lung inflammation. As
previously mentioned, SPC-HA/TCR-HA mice develop a
spontaneous pneumonitis due to the concomitant expression of the neo-self antigen influenza HA in AEC II and a
transgenic TCR specifically recognizing an I-Ed-restricted
epitope from this particular antigen [15]. Thus, lung
inflammation occurs as a consequence of CD4+ T cell recognition of a single alveolar epithelial "self antigen".

For gene expression analysis, RNA prepared from AEC II
was subjected to differential gene expression analysis
using oligonucleotide microarrays. An important advantage of this technology is that every analyzed gene is represented by sixteen independent probe pairs which
together establish the basis for statistical evaluations of
the respective signals. Therefore, only the genes that are
reproducibly regulated are included in the analysis. For
each gene fulfilling these criteria, the average fold change
in expression for AEC II from the inflamed lung of SPCHA/TCR-HA and healthy lung of SPC-HA mice was calculated and the ratio was depicted on a base-2 logarithmic
scale. To establish the basal expression level of analyzed
genes in AEC II under non-pathologic conditions, an
alignment of AEC II derived from the healthy and
inflamed lungs was also performed, in duplicate arrays.
The number of "present calls" (42.1 to 44.7%) as calculated by the statistical detection algorithm of Affymetrix
was similar to data obtained from analysis of other types
of cells, e.g. T lymphocytes isolated by cell sorting [15].
The purity and integrity of isolated AEC II was examined
using basal gene expression levels of selected genes in AEC
II isolated from the lungs of healthy SPC-HA mice. Consistent with results obtained by immunofluorescence
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Figure
CD4+ T 1cell recognition of alveolar epithelial antigen results in airway inflammation and AEC II hypertrophy
CD4+ T cell recognition of alveolar epithelial antigen results in airway inflammation and AEC II hypertrophy.
(A) Histological examination of lungs from healthy SPC-HA (a and a'), SPC-HA six days after adoptive transfer of HA-specific
CD4+ T cells (b, b') and SPC-HA/TCR-HA double transgenic mice (c, c'). Lung sections were stained with H&E. Black arrows
indicate AEC II, red arrows indicate lymphocytes. No lesions were detectable in the lung of SPC-HA mice. Specifically, type II
pneumocytes were completely unchanged (a, a'). A moderate, perivascular and peribronchiolar infiltration with mature lymphocytes was detected in the lung of SPC-HA mice after transfer with HA-specific CD4+ T cells. Adjacent to these infiltrations,
a slight connective tissue edema and a mild infiltration with neutrophils were observed. Type II pneumocytes in the vicinity of
the lymphocytic infiltrations were moderately hypertrophic. A few alveolar macrophages were present in the alveoli (b, b').
Moderate, multifocal, perivascular and peribronchiolar infiltrations with lymphocytes were present in the lung of SPC-HA/
TCR-HA double transgenic mice. Type II pneumocytes close to the lymphocytic infiltrations were mildly activated and hypertrophic (c, c'). (B) Histological results were corroborated morphometrically by measuring AEC II surface and perimeter to
quantify the degree of cellular hypertrophy (n = 15, 3 mice with 5 AEC II per mouse; ± standard deviation). AEC II surface:
SPC-HA vs SPC-HA Transfer: P < 0,001), SPC-HA vs SPC-HA/TCR-HA (P < 0,0001), SPC-HA transfer vs SPC-HA/TCR-HA (P
< 0,0001). AEC II perimeter: SPC-HA vs SPC-HA Transfer: P < 0,001), SPC-HA vs SPC-HA/TCR-HA (P < 0,001), SPC-HA
transfer vs SPC-HA/TCR-HA (P < 0,001). All Student's t-test.

microscopy (Figure 3), sorted AEC II cells showed high
mRNA expression levels for SP-A, SP-B, SP-C and SP-D
(data not shown). Comparison of expression profiles of
AEC II cells from healthy and inflamed lungs revealed 322
genes that exhibited more than a two-fold expression
change. Among these, 288 encode proteins of known or
putative function (depicted in Figure 4), and the remaining 34 genes are currently described as expressed sequence
tags (ESTs) or encoding unknown proteins. The full list of
differentially expressed genes is accessible online at [19].

Regulated genes were grouped into 11 functional classes
by their putative functions (Table 1). Among the genes
most significantly regulated in association with interstitial
inflammation were genes encoding the chemokine
CCL20, matrix metalloproteinases 2 and 3, and tissue
inhibitor of metalloproteinase 1. Also, strong down-regulation of expression of several genes associated with cell
adhesion, including procollagen type XIV, alpha 1,
fibronectin 1 and dermatopontin, was observed in AEC II
cells isolated from the inflamed lung. Interestingly,
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as lipoprotein lipase, prosaponin and metallothionein 2)
and cytoskeletal function (such as gelsolin and vimentin)
were down-regulated, genes involved in antigen processing and presentation, such as MHC class II subunits, proteasome subunits and beta-2 microglobulin exhibited
elevated expression in the inflamed lung. These genes
along with other potentially interesting genes differentially expressed in AEC II cells isolated from the inflamed
lung, are listed in Table 1.
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Figure
Intracellular
2 cytokine staining in CD4+ T cells
Intracellular cytokine staining in CD4+ T cells. CD4+ T
cells from the lung or bronchial lymph nodes (BLN) from
either TCR-HA control mice, SPC-HA/TCR-HA double
transgenic mice or SPC-HA mice adoptively transferred with
HA-specific CD4+ T cells were analyzed by FACS for the
expression of interleukin 2 and interferon γ.

SPD
SP
-D

Maclura pomifera

Figure 3 cellofsorting
Purification
activated
alveolar type II epithelial cells by fluorescencePurification of alveolar type II epithelial cells by fluorescence-activated cell sorting. (A) Cell suspension
obtained by enzymatic tissue disintegration and subsequent
sequential filtration was labelled with antibodies to CD45,
CD16, CD32, CD11b, and F4/80. Antibody negative AEC II
were further distinguished from other cells by size and granularity. Reanalysis of sorted cells demonstrated an extremely
low frequency of contaminating hematopoetic cells. (B)
Sorted cells express surfactant proteins A, B, C and D. Cytospins of sorted AEC II cells were stained for the surfactant
proteins A, B, C and D. Almost all cells were found to be
positive for all four surfactant proteins. A, B, C and D represent phase contrast microscopy, A', B', C', and D' represent
immunohistochemical stainings for the corresponding surfactant protein. (C) Staining of sorted AEC II with Maclura
pomifera lectin revealed high purity of isolated cells. Black
histogram indicates staining with the lectin, grey histogram
indicates unstained cells.
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cytoskeletal function, and antigen presentation and
processing were analyzed for changes in expression over
time (Figure 5). In addition, AEC II expression of selected
chemokines in the acute phase of lung inflammation was
further validated by quantitative real-time RT-PCR analyses (Figure 6). Interestingly, for the majority of genes analyzed the changes in the expression level observed acutely
mirrored the chronic changes observed in AEC II isolated
from the lung of SPC-HA/TCR-HA mice at 16–20 weeks.
Thus, the alterations of AEC II gene expression profiles
which occurred early after T cell recognition of alveolar
antigen tended to persist into the chronic phase of inflammation. For example, there was a rapid up-regulation of
MHC class II subunit expression, but decreased expression
of cytoskeletal genes both early after T cell transfer as well
as in AEC II isolated from SPC-HA/TCR-HA mice (Table 1
and Figure 4, 5). However, there were notable exceptions
to this pattern, such as was observed with CXCL13 expression, which was clearly down-regulated in AEC II isolated
from the chronically inflamed lung of SPC-HA/TCR-HA
double transgenic mice but induced acutely in AEC II cells
3 and 6 days after T cell transfer (confirmed by real-time
RT-PCR; Figures 5, 6).

types in the induction and progression of inflammatory
pulmonary processes, animal models represent tools of
extraordinary value. To explore the contribution of AEC II
gene expression in T cell mediated lung inflammation, we
made use of a transgenic mouse model of chronic T cell
mediated lung inflammation that mimics some of the features of the interstitial lung discussed above, and that was
previously established [15]. We report here the application of flow cytometry to efficiently isolate alveolar type II
epithelial cells from mouse lungs by negative selection
followed by whole genome transcriptome analysis. Gene
expression profiling has emerged as an important tool in
the characterization of complex molecular responses in
inflammation and disease. The use of isolated cellular
subpopulations has proven to be more informative than
whole tissues in dissecting the roles of individual cell
types in disease development in general, and immune regulation in particular. Comparative genetic fingerprinting
of AEC II isolated from healthy mice and mice suffering
from severe lung inflammation promises to be extremely
informative regarding the role of AEC II in the induction
and regulation of pulmonary immunity and inflammation.

Discussion

Though confirmation of protein expression is essential,
morphological changes in AEC II phenotype and array
data suggest very active participation of alveolar epithelial
cells in inflammatory processes in the lung. Using Affymetrix GeneChip experiments we identified a heterogeneous
set of more than 322 genes differentially expressed in AEC
II under pathophysiologic conditions. Variations in signal
intensities between experimental repetitions may account
for slight differences in the disease progression in individual pooled mice as well as for differences in cRNA synthesis and hybridization efficiencies between two array
experiments. To exclude as far as possible that changes in
gene expression occur as a consequence of the isolation
procedure, care was taken to purify AEC II from the different mouse pools strictly following the described protocol,
i.e. avoiding variations of incubation times or temperature, etc. Therefore, the influence of cell isolation procedure on gene expression in AEC II cells from healthy
versus inflamed lungs will subtract from each other and
account for changes in the molecular signature of AEC II
as a consequence of CD4+ T cell mediated lung inflammation.

A significant number of lung diseases are presumed to be
T cell mediated based in part on the observation of T cell
accumulation at sites of disease activity, particularly the
interstitial lung diseases (ILD). The ILD represent a broad
group of heterogeneous disorders and the participation of
CD4+ T cells in various forms of ILD has been suggested.
Sarcoidosis, idiopathic interstitial pneumonias, autoimmune connective tissue diseases and pulmonary hemorrhage syndromes represent some of the major categories
of ILD. Sarcoidosis, for example, appears to be associated
with an exaggerated cellular immune response to an
unknown antigen and CD4+ Th1 lymphocytes are important effectors of pulmonary injury in this disease [20,21].
In addition to ILD, it has been postulated that T cells are
important contributors in other pulmonary disorders
such as chronic obstructive pulmonary disease (COPD)
and asthma [22,23]. In these, it is hypothesized that cigarette smoke or allergen induced immune responses can,
under certain conditions, progress to T cell mediated
autoimmune disease. Recently it has been suggested that
smoking-induced emphysema may represent an autoimmune disease of sorts, in which the presence of Th1
responses to a specific lung antigen correlates with
emphysema severity [21]. Furthermore, oligoclonal CD4+
T cell expansion has been suggested to contribute to the
pathogenesis of obliterative bronchiolitis [24]. Although
there is growing evidence that CD4+ T cells contribute to
various pulmonary disorders, little is known concerning
the role of AEC II cells in T cell mediated lung injury. To
expand our understanding of the roles of selected cell

The differential expression of several immune modulating
molecules like TGF-β3 or the various chemokines and
chemokine ligands observed, suggests that in an inflamed
environment AEC II may interact with resident and
mobile neighbour cells via secreted and diffusible signals
[9]. Members of the transforming growth factor-beta family are linked to proliferation or secretory activities of AEC
II. It has been shown that TGF-β3 production by AEC II is
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Table 1: Selected genes differentially expressed in AEC II upon airway inflammation

Gene (functional category)

Symbol

SPC-HA/TCR-HA/SPC-HA
Array1
Array2

Fold change
Array1/Array2

Genes associated with cell cycle
cyclin D2
transforming growth factor, beta 3

Ccnd2
Tgfb3

208/507
93/311

250/648
87/188

-2,1/-2,1
-3,0/-2,2

Col4a5
Col14a1
Fn1
Dpt
Cldn18

89/208
194/2003
252/2564
250/5627
592/261

72/224
142/1858
407/2813
277/3997
1845/445

-1,9/-2,8
-9,8/-13,1
-9,9/-8,6
-11,8/-11,6
2,3/3,9

H2-Q7
H2-Ea
H2-Ab1
H2-Aa
H2-Eb1
H2-DMa
Psmb7
Psmb8
Psmb9
B2m
Tap1

1386/85
5720/2661
2217/1008
4028/2019
2072/1013
406/291
418/222
664/223
317/122
8579/4177
277/107

1666/109
5207/2187
3971/1286
6314/1859
2882/1100
961/293
252/117
634/310
528/244
8784/3119
283/120

17,6/20,3
2,2/2,4
2,1/2,9
1,9/1,8
1,9/2,3
1,6/3,2
2,9/2,2
2,5/2,2
2,8/2,5
2,1/2,9
2,4/3,0

Kcnj15
Lcn2
Scnn1a

946/253
11034/3130
405/292

1160/231
13952/1966
448/225

4,0/4,9
3,6/7,4
2,1/2,4

CXCL1
CXCL13
CXCL12
CCL20
CCL11

313/96
128/556
253/1827
188/11
39/302

235/64
100/634
211/1541
141/10
30/162

2,5/3,1
-4,5/-5,9
-6,7/-7,4
17,1/11,5
-8,5/-4,1

MMP2
MMP3
MMP23
TIMP1
TIMP2
TIMP3

154/1788
51/599
102/685
54/842
313/2265
623/2935

116/1504
67/547
143/568
70/569
388/2576
434/3363

-10,8/-10,3
-10,8/-10,9
-6,2/-3,8
-11,1/-8,6
-8,6/-8,5
-3,0/-6,0

Eln
Gsn
Vim
Tuba1

150/524
1438/16701
204/1974
1285/6486

177/398
1620/15697
308/2043
1145/6076

-4,1/-2,5
-8,1/-9,7
-9,6/-6,5
-4,7/-5,3

Genes associated with cell adhesion
procollagen, type IV, alpha 5
procollagen, type XIV, alpha 1
fibronectin 1
dermatopontin
claudin 18
Genes associated with antigen presentation and processing
major histocompatibility complex, class I, B
major histocompatibility complex, class II, DR alpha
major histocompatibility complex, class II, DQ beta 2
major histocompatibility complex, class II, DQ alpha 1
major histocompatibility complex, class II, DR beta 1
major histocompatibility complex, class II, DM alpha
proteasome (prosome, macropain) subunit, beta type, 7
proteasome (prosome, macropain) subunit, beta type, 8
proteasome (prosome, macropain) subunit, beta type, 9
beta-2-microglobulin
transporter 1 ATP-binding cassette, sub-family B (MDR/TAP)
Genes associated with transport
potassium inwardly-rectifying channel, subfamily J, member 15
lipocalin 2
sodium channel, nonvoltage-gated, type I, alpha polypeptide
Genes associated with immune response
Chemokine (C-X-C motif) ligand 1
Chemokine (C-X-C motif) ligand 13
Chemokine (C-C motif) ligand 12
Chemokine (C-X-C motif) ligand 20
chemokine (C-C motif) ligand 11
Genes associated with proteolysis and peptidolysis
Matrix metalloproteinase 2
Matrix metalloproteinase 3
Matrix metalloproteinase 23
Tissue inhibitor of metalloproteinase 1
Tissue inhibitor of metalloproteinase 2
Tissue inhibitor of metalloproteinase 3
Genes associated with cytoskelett
elastin
gelsolin
vimentin
tubulin, alpha 1
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Table 1: Selected genes differentially expressed in AEC II upon airway inflammation (Continued)

Genes associated with metabolism
vanin 1
5,10-methylenetetrahydrofolate reductase
paraoxonase 1
hexosaminidase B

Vnn1
Mthfr
Pon1
Hexb

1752/200
141/300
460/901
94/303

993/181
114/276
334/774
93/228

9,6/6,3
-2,0/-2,2
-2,3/-2,4
-2,5/-2,2

Igfbp7
Lpl
Psap
Fgfr3
Il11ra1

1356/4715
504/1542
236/761
160/345
88/428

1849/5414
228/1495
319/963
165/304
146/350

-3,8/-2,52
-3,3/-5,5
-3,9/-3,0
-2,0/-3,2
-2,7/-2,7

Anxa11
Mt2

1230/2328
118/737

866/1949
153/758

-1,8/-2,4
-5,8/-7,1

Tef
Cri1
Tcf4
Ndn

350/189
179/352
92/462
216/1425

429/203
116/324
142/519
152/1895

2,2/2,3
-2,2/-3,1
-5,0/-4,3
-5,5/-8,7

Smo
Fhl1

148/382
704/3478

115/335
454/3561

-2,6/-2,7
-4,7/-6,4

Genes associated with signal transduction
insulin-like growth factor binding protein 7
lipoprotein lipase
prosaposin
fibroblast growth factor receptor 3
interleukin 11 receptor, alpha chain 1
Genes associated with signal transduction
annexin A1
metallothionein 2
Genes associated with transcription
thyrotroph embryonic factor
CREBBP/EP300 inhibitory protein 1
transcription factor 4
necdin
Genes associated with development
smoothened homolog (Drosophila)
four and a half LIM domains 1

Differential gene expression was investigated by Affimetrix Gene Chip technology in AEC II from diseased SPC-HA/TCR-HA and healthy SPC-HA
mice (n = 3). For each population two independent experiments were performed and data obtained from individual experiments are depicted. The
table represents a compilation of regulated genes.

dynamically down-regulated during the proliferative
phase of recovery from acute hyperoxic injury [25]. Consistent with this, TGF-β3 expression was down-regulated
in AEC II from the inflamed lung, and since AEC II represent the stem cells for alveolar type I epithelial cells (AEC
I), this suggests a role of the TGF-β family in AEC II proliferative responses and/or the cellular hypertrophy of AEC
II observed in the inflamed lung.
In addition to TGF-β3, the CXC chemokines CXCL2,
CXCL13 and CXCL12 were also differentially expressed in
AEC II from inflamed compared to healthy lungs (Figure
4, 5, 6, Table 1). These chemokines praticipate in the process of attracting various cell populations into the lung.
CXCL12 and CXCL13 bind to CXCR4 and CXCR5, which
are primarily expressed on T lymphocytes or on circulating fibrocytes [26]. Interestingly, CXCL12 and CXCL13
expression was induced shortly after T cell recognition of
epithelial antigen (Figure 5, 6 and data not shown) and
massive lymphocytic infiltrates were observed shortly

after T cell transfer (data not shown). Furthermore, downregulation of T cell chemoattractants was evident at later
stages of inflammation (Figure 4 and Table 1) and could
contribute to a more controlled infiltration of specific T
cells into the lung. Accordingly it has been shown that
CXCL13 plays an important role in the development of
inducible bronchus associated lymphoid tissue (iBALT) in
respiratory immunity [27] by attracting T lymphocytes. It
has been suggested that infection or inflammation triggers
the organization of lymphoid structures in the lung of
both mice and humans [28,29], though this is somewhat
controversial. These structures do not fit the classical definition of BALT, as they are not formed independently of
antigen [30,31]. Because the iBALT appears in the lung
only after infection or inflammation, it is generally
assumed that iBALT is simply an accumulation of effector
cells that were initially primed in conventional lymphoid
organs. The neo-formation of iBALT is caused by inflammatory responses which directly promote the recruitment,
priming and expansion of antigen-specific lymphocytes
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Figure
Heat
healthy
map
SPC-HA
4 including
mice
genes differentially expressed in AEC II cells isolated from lungs of diseased SPC-HA/TCR-HA as well as
Heat map including genes differentially expressed in AEC II cells isolated from lungs of diseased SPC-HA/TCRHA as well as healthy SPC-HA mice. Red indicates induction of gene expression, green indicates repression (+2: bright
red; -2: bright green). Black indicates no changes. Blue squares indicate genes further highlighted in Table 1. Genes were considered to be regulated whose expression was at least twofold increased or decreased.
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Chemokine expression in AEC II after adoptive CD4+
T cell transfer into SPC-HA mice. AEC II cells were isolated from the lung of SPC-HA mice one (n = 3), three (n =
3) and six (n = 3) days after adoptive transfer of HA-specific
CD4+ T cells. Cells were subjected to quantitative real-time
RT-PCR analyses. mRNA expression levels of CXCL1,
CCL20, CXCL13, CCL11, CXCL2, and RPS9 (as internal
control) were analyzed in real-time RT-PCR assays. Relative
mRNA amounts were normalized with respect to expression
levels in AEC II cells isolated from SPC-HA mice not receiving CD4+ T cell transfer (fold change = 1).
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matory responses, down-regulate CXCL13 expression in
order to counteract new formation of iBALT and infiltration of specific T cells.
The chemokine CXCL2 is involved in attraction of polymorphonuclear granulocytes to sites of infection [32].
These neutrophils play an important role as regulators of
immune responses through release of cytokines such as
IL-1, IL-3, IL-6, IL-12, tumor necrosis factor-α (TNF-α) or
TGF-β as well as chemokines such as CCL2 (MCP-1) or
CCL20 (MIP-3α) [33,34].
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Time course of gene expression in AEC II after adoptive CD4+ T cell transfer into SPC-HA mice. AEC II
cells were isolated from the lung of SPC-HA mice one (n =
3), three (n = 3) and six (n = 3) days after adoptive transfer
of HA-specific CD4+ T cells. Cells were subjected to microarray analysis and the level of gene expression over time is
depicted for selected genes. Data obtained from two different experiments are represented.

[27]. It is interesting to speculate that AEC II in SPC-HA/
TCR-HA double transgenic mice, after the initial inflam-

Elevated expression of CCL20 by AEC II has been shown
to attract other pro-inflammatory cells [34,35]. CCL20,
which was dramatically up-regulated in the inflamed lung
(Figure 4, 5, 6, Table 1), has been shown to be constitutively produced by AEC II cells and can attract immature
dendritic cells (imDC) to the lung [36,37]. Immature dendritic cells are known to exert immune modulatory functions and may contribute to the establishment of a
controlled immune response in SPC-HA/TCR-HA double
transgenic mice. In contrast to CCL20, CCL11 (eotaxin),
an eosinophil chemoattractant, was dramatically downregulated in AEC II from the inflamed lung (Figure 4 and
6, Table 1). Not surprisingly, anti-CCL11 reduced eosinophils infiltration of the lungs of RSV-infected mice. In
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addition, however, anti-CCL11 also caused inhibited
CD4-T-cell influx [38]. Together, these data indicate an
active immune regulatory function of AEC II in inflammatory pneumonitis involving the expression and secretion
of soluble mediators that may affect other immune cells
with regulatory features which may amplify, or interfere
with,
inflammatory
responses
in
the
lung.
Although gene expression data provide evidence that AEC
II may (either directly or indirectly) exhibit immune regulatory functions, we also identified genes involved in the
induction of T cell mediated immunity. In this context it
is interesting to note that the expression levels for molecules involved in antigen processing and presentation
were up-regulated in AEC II obtained from diseased mice.
For instance, increased expression of molecules needed
for the MHC class-II restricted antigen presentation, like
H2-Ea and H2-Ab1, but also invariant chain (CD74), was
observed. Furthermore, expression of genes encoding for
the transporter associated with antigen processing (TAP1)
and various proteasomal subunits, all related with MHC
class I presentation, were increased (Figure 4, 5, 6, Table
1). This effect was observed both in SPC-HA/TCR-HA
mice that exhibit chronic inflammation as well as in AEC
II from SPC-HA mice shortly after T cell transfer. Up-regulation of MHC encoded genes is likely the result of interferon (IFN)-γ production by the CD4+ T cells, and is well
known to induce the transcription of genes encoded
within the MHC region. Based on our previous observation in an adoptive transfer model for CD8+ T cell mediated pulmonary inflammation, as well as in cell culture
experiments [13,14,39], we have strong evidence that T
cell antigen recognition triggers inflammatory gene
expression in AEC II cells, a significant portion of which is
IFN-γ dependent. Although CD4+ T cell derived IL-2 and
IFN-γ are likely pro-inflammatory mediators that trigger
AEC II gene expression in SPC-HA/TCR-HA mice or SPCHA mice after adoptive T cell transfer, it is possible that
other T cell derived factors contribute to the observed
changes in AEC II gene expression, such as TNF-α.
Further genes differentially expressed in AEC II upon airway inflammation are cyclin A2 and cyclin D2, both
involved in cell cycle regulation [40,41] and several
matrix metalloproteinases (MMP) and tissue inhibitor
metalloproteinases (TIMP), all of which are critical in
repair and remodelling in response to injury [42,43]. In
addition to these, genes with roles in adhesion, cytoskeletal function, transport, metabolism, signal transduction,
transcription and development suggest that AEC II are
active participants in all aspects of immune regulation,
inflammation and responses to injury. The impact of
these gene products on the ethiopathogenesis of pulmonary inflammation remain to be elucidated in further
detail.

http://respiratory-research.com/content/8/1/47

Conclusion
We have developed a new AEC II isolation protocol based
on flow cytometric negative selection for the isolation of
cell populations of high purity and viability. Employing
this technique, we determined the genome-wide profile of
gene expression in response to T cell-mediated interstitial
pneumonitis. Overall, these results provide a detailed
description of AEC II gene expression under pathophysiologic, autoimmune conditions. Differentially expressed
genes of diverse molecular functions have been identified
that may be critical for numerous physiologic activities,
some of which may be currently unappreciated. Data
obtained by such analysis will help to understand the
function of these important immune cells in the respiratory system and may point out strategies for intervention
in the progression of chronic inflammatory processes in
the lung.
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